<DOC>
<DOCNO>
EP-0011366
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
C07K-1/113 C07C-231/00 C07K-14/435 A61K-38/04 C07K-1/00 C07K-14/655 A61P-3/08 C07K-14/575 A61P-3/00 A61P-3/10 
</IPC-CLASSIFICATIONS>
<TITLE>
synthetic peptides, their preparation, pharmaceutical formulations containing them and intermediates for their preparation
</TITLE>
<APPLICANT>
lilly co elius<sep>eli lilly and company<sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us<sep>
</APPLICANT>
<INVENTOR>
shields james edwinus<sep>shields, james edwin<sep>shields, james edwin7229, wynter wayindianapolis, indiana 46250us<sep>
</INVENTOR>
<ABSTRACT>
the tetradecapeptides of the formula    wherein x is h-ala-d-ala, h-d-ala-gly, or h-d-val-gly; and x¹  is ala-leu, ala-phe, ala-d-phe, d-ala-phe, or d-ala-cha; or  the non-toxic, pharmaceutically acceptable acid addition salts  thereof; inhibit secretion of growth hormone, while not mat­ erially inhibiting the secretion of insulin or glucagon.  the  compounds are prepared by oxidation of intermediates of the  formula   x-cys-lys-x¹-phe-d-trp-lys-thr-d-phe-thr-ser-cys-oh (iv) 
</ABSTRACT>
</TEXT>
</DOC>
